Patent details
EP4376832
Title:
OBICETRAPIB FOR USE IN TREATING OF CARDIOVASCULAR DISEASE (CVD) IN HIS HYPORESPONDERS
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP4376832
WO Application Number:
EP2022070780
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP22754412.9
WO Publication Number:
WO2023006657
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Netherlands (NL)
Publications:
Dates
Filing date:
25/07/2022
Grant date:
25/03/2026
EP Publication Date:
05/06/2024
WO Publication Date:
02/02/2023
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/03/2026
EP B1 Publication Date:
25/03/2026
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
24/07/2042
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
25/03/2026
Name:
NewAmsterdam Pharma B.V.
Address:
Gooimeer 2-35, 1411 DC Naarden, Netherlands (NL)
Inventor
1
Name:
KASTELEIN, Johannes Jacob Pieter
Address:
1411 DC Naarden, Netherlands (NL)
2
Name:
DITMARSCH, Marc
Address:
1411 DC Naarden, Netherlands (NL)
3
Name:
DAVIDSON, Michael Harvey
Address:
1411 DC Naarden, Netherlands (NL)
Priority
Priority Patent Number:
21187721
Priority Date:
26/07/2021
Priority Country:
European Patent Office (EPO) (EP)
Classification
IPC or IDT classification:
A61K 31/40 ;
A61K 31/505 ;
A61K 31/506 ;
A61P 3/06 ;
Publication
Bulletin
Bulletin Heading:
EP2
Journal edition number:
12/26
Publication date:
25/03/2026
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202614
Publication date:
01/04/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed
2
Issue number:
202613
Publication date:
25/03/2026
Description:
Grant (B1)
Annual Fee
Annual Fee(s) Due Date:
31/07/2026
Annual Fee Number:
5
Annual Fee Amount:
100 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type